More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin
Daptomycin is a cyclic lipopeptide antibiotic, which was discovered in 1987 and entered the market in 2003. To date, it serves as last resort antibiotic to treat complicated skin infections, bacteremia, and right-sided endocarditis caused by Gram-positive pathogens, most prominently methicillin-resistant Staphylococcus aureus. Daptomycin was the last representative of a novel antibiotic class that was introduced to the clinic. It is also one of the few membrane-active compounds that can be applied systemically. While membrane-active antibiotics have long been limited to topical applications and were generally excluded from systemic drug development, they promise slower resistance development than many classical drugs that target single proteins. The success of daptomycin together with the emergence of more and more multi-resistant superbugs attracted renewed interest in this compound class. Studying daptomycin as a pioneering systemic membrane-active compound might help to pave the way for future membrane-targeting antibiotics. However, more than 30 years after its discovery, the exact mechanism of action of daptomycin is still debated. In particular, there is a prominent discrepancy between in vivo and in vitro studies. In this review, we discuss the current knowledge on the mechanism of daptomycin against Gram-positive bacteria and try to offer explanations for these conflicting observations.
Citations by journals
1
2
3
4
5
|
|
ACS Infectious Diseases
|
ACS Infectious Diseases
5 publications, 7.81%
|
Pharmaceutics
|
Pharmaceutics
3 publications, 4.69%
|
Antibiotics
|
Antibiotics
3 publications, 4.69%
|
Microbiology spectrum
|
Microbiology spectrum
3 publications, 4.69%
|
Angewandte Chemie - International Edition
|
Angewandte Chemie - International Edition
2 publications, 3.13%
|
Microbiology
|
Microbiology
2 publications, 3.13%
|
Frontiers in Microbiology
|
Frontiers in Microbiology
2 publications, 3.13%
|
Angewandte Chemie
|
Angewandte Chemie
2 publications, 3.13%
|
Organic and Biomolecular Chemistry
|
Organic and Biomolecular Chemistry
2 publications, 3.13%
|
Advanced Science
|
Advanced Science
1 publication, 1.56%
|
mBio
|
mBio
1 publication, 1.56%
|
Analytical Chemistry
|
Analytical Chemistry
1 publication, 1.56%
|
Biomolecules
|
Biomolecules
1 publication, 1.56%
|
Microorganisms
|
Microorganisms
1 publication, 1.56%
|
Polymers
|
Polymers
1 publication, 1.56%
|
Membranes
|
Membranes
1 publication, 1.56%
|
Frontiers in Cellular and Infection Microbiology
|
Frontiers in Cellular and Infection Microbiology
1 publication, 1.56%
|
Frontiers in Bioengineering and Biotechnology
|
Frontiers in Bioengineering and Biotechnology
1 publication, 1.56%
|
Frontiers in Immunology
|
Frontiers in Immunology
1 publication, 1.56%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
1 publication, 1.56%
|
Scientific Reports
|
Scientific Reports
1 publication, 1.56%
|
Amino Acids
|
Amino Acids
1 publication, 1.56%
|
Journal of Emergency Medicine
|
Journal of Emergency Medicine
1 publication, 1.56%
|
Applied Microbiology and Biotechnology
|
Applied Microbiology and Biotechnology
1 publication, 1.56%
|
Nature Communications
|
Nature Communications
1 publication, 1.56%
|
Asian Journal of Pharmaceutical Sciences
|
Asian Journal of Pharmaceutical Sciences, 1, 1.56%
Asian Journal of Pharmaceutical Sciences
1 publication, 1.56%
|
PLoS Pathogens
|
PLoS Pathogens
1 publication, 1.56%
|
Microbiology and Molecular Biology Reviews
|
Microbiology and Molecular Biology Reviews
1 publication, 1.56%
|
Journal of Peptide Science
|
Journal of Peptide Science
1 publication, 1.56%
|
1
2
3
4
5
|
Citations by publishers
2
4
6
8
10
12
14
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
13 publications, 20.31%
|
American Society for Microbiology
|
American Society for Microbiology
8 publications, 12.5%
|
Wiley
|
Wiley
7 publications, 10.94%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
7 publications, 10.94%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
6 publications, 9.38%
|
Springer Nature
|
Springer Nature
5 publications, 7.81%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
3 publications, 4.69%
|
Microbiology Society
|
Microbiology Society
2 publications, 3.13%
|
Elsevier
|
Elsevier
1 publication, 1.56%
|
Shenyang Pharmaceutical University
|
Shenyang Pharmaceutical University, 1, 1.56%
Shenyang Pharmaceutical University
1 publication, 1.56%
|
Public Library of Science (PLoS)
|
Public Library of Science (PLoS)
1 publication, 1.56%
|
eLife Sciences Publications
|
eLife Sciences Publications
1 publication, 1.56%
|
Cold Spring Harbor Laboratory
|
Cold Spring Harbor Laboratory
1 publication, 1.56%
|
2
4
6
8
10
12
14
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.